DNA cytometry confirms the utility of the Bethesda System for the classification of Papanicolaou smears

Cancer

Volumn 93, Issue 3, 2001, Pages 222-228

  Bollmann, Reinhard ^a   Bollmann, Magdolna ^b   Henson, Donald E ^a,b   Miklos Bodo, M D ^c  

^a UNIVERSITY OF BONN   (Germany)

^b NATIONAL CANCER INSTITUTE   (United States)

^c ST JOHN'S HOSPITAL   (Hungary)

Author keywords

Bethesda System; DNA cytometry; Munich II Nomenclature; Papanicolaou smear; Uterine cervical carcinoma

Indexed keywords

DNA;

ANEUPLOIDY; ARTICLE; CANCER CLASSIFICATION; CYTOMETRY; DIPLOIDY; DNA DETERMINATION; FEMALE; HUMAN; HUMAN CELL; INTERMETHOD COMPARISON; MAJOR CLINICAL STUDY; PAPANICOLAOU TEST; POLYPLOIDY; PRIORITY JOURNAL; UTERINE CERVIX CARCINOMA IN SITU; UTERINE CERVIX DYSPLASIA;

CARCINOMA IN SITU; CERVICAL INTRAEPITHELIAL NEOPLASIA; DNA, NEOPLASM; FEMALE; FOLLOW-UP STUDIES; HISTOCYTOCHEMISTRY; HUMANS; PREDICTIVE VALUE OF TESTS; SENSITIVITY AND SPECIFICITY; UTERINE CERVICAL DYSPLASIA; UTERINE CERVICAL NEOPLASMS; VAGINAL SMEARS;

EID: 0035948196     PISSN: 0008543X     EISSN: None     Source Type: Journal    
DOI: 10.1002/cncr.9033     Document Type: Article

References (84)

1. Terminology. International Academy of Cytology Task Force summary. Diagnostic Cytology Towards the 21st Century: An International Expert Conference and Tutorial
2. The Munich nomenclature
3. Reporting cervical intra-epithelial neoplasia (CIN): Intra- and interpathologist variation and factors associated with disagreement
4. Dysplasia. A real concept or a misnomer?
5. DNA changes in progressive cervical intraepithelial neoplasia
6. Diagnosis of prospective malignancy of cervix dysplasia using DNA cytometry
7. Prognostische validität der DNA-bildzytometrie bei dysplasien in gebärmutterhalsabstrichen
8. The influence of chromatin compactness on the stoichiometry of the Feulgen-Schiff procedure studied in model films. I. Theoretical kinetics and experiments with films containing isolated deoxyribonucleic acid
9. The influence of chromatin compactness on the stoichiometry of the Feulgen-Schiff procedure studied in model films. II. Investigations on films containing condensed or swollen chicken erythrocyte nuclei
10. Consensus report of the European Society for Analytical Cellular Pathology task force on standardization of diagnostic DNA image cytometry
11. Aspects of scanning microdensitometry. I. Stray light (glare)
12. Glare-correction in DNA image cytometry
13. Morphological correlation of human papillomavirus infection of matched cervical smears and biopsies from patients with persistent mild cervical cytological abnormalities
14. Diagnostic and prognostic value of DNA cytometry in gynecologic cytology
15. Über den chemischen aufbau der strukturen des zellkernes
16. Cytophotometrische untersuchungen am portiocarcinom und seinen vorstufen
17. Zur krebsdiagnostik an vaginalen zellausstrichen mittels cytophotometrischer messungen
18. Der DNS-gehalt des normalen plattenepithels des carcinoma in situ und des invasiven carcinoms der portio
19. Fluorescence cytophotometric determination of nuclear DNA. Comparative study of the acriflavine-feulgen and the ethidiumbromide staining reactions
20. DNA content and chromatin pattern analysis on cervical carcinoma in situ
21. DNA-content of dysplastic cells of the uterine cervix
22. Feulgen-hydrolysis profiles in cells exfoliated from the cervix uteri: A potential aid in the diagnosis of malignancy
23. DNA quantification is technically feasible and of value in cervical smear samples: Possible applications for determination of progression in low grade dyskaryosis
24. DNA content of condyloma acuminatum
25. Koilocytotic lesions of the cervix. The relationship of mitotic abnormalities to the presence of papillomavirus antigens and nuclear DNA content
26. Use of fluorescent in situ hybridization to detect aneuploidy in cervical dysplasia
27. Advanced-stage cervical carcinomas are defined by a recurrent pattern of chromosomal aberrations revealing high genetic instability and a consistent gain of chromosome arm 3q
28. Gain of chromosome 3q defines the transition from severe dysplasia to invasive carcinoma of the uterine cervix
29. Chromosome 1 abnormalities in cervical carcinoma
30. A quality-control procedure on cervical lesions for the comparison of cytology and histology
31. DNA ploidy profiles as prognostic indicators in CIN lesions
32. DNA-cytometric diagnosis of prospective maligancy in borderline lesions of the uterine cervix
33. DNA-zytometrie zur qualitätskontrolle in der gynäkologischen zytologie
34. DNA-cytometric diagnosis of prospective malignancy in borderline lesions of the uterine cervix
35. Adenocarcinoma in situ of the cervix uteri
36. Diagnosis of prospective malignancy in koilocytic dysplasias of the cervix with DNA cytometry
37. DNA content measurement and in situ hybridization in condylomatous cervical lesions
38. Identifying high-risk precursors of cervical cancer. How and why
39. DNA cytometry in post-irradiation cervical-vaginal smears
40. Prognostic significance of DNA cytometry of postirradiation cervicovaginal smears
41. Flow cytometric DNA analysis of the human cervix affected by human papillomavirus and/or intraepithelial neoplasia
42. Definition of precursors
43. Human papillomavirus standardization and DNA cytophotometry in cervical intraepithelial neoplasia
44. Cytophotometric determinations of DNA, histone, arginine, lysine, and their concentrations in eu- and heterochromatin of the cell nucleus of dysplasias, carcinoma in situ, and carcinoma of the human cervix uteri
45. Nuclear DNA analysis of koilocytic and premalignant lesions of the uterine cervix
46. DNA aneuploidy and infection of human papillomavirus type 16 in preneoplastic lesions of the uterine cervix: Correlation with progression to malignancy
47. Microphotometric DNA analysis in moderate dysplasia of the uterine cervix. Correlation to the progression and regression of the lesion
48. Microphotometric nuclear DNA analysis in cervical dysplasia of the uterine cervix: Its relation to the progression to malignancy and regression to normalcy
49. Predictive value of morphological nuclear parameters and DNA ploidy pattern in precancerous lesions of the uterine cervix
50. Human papillomavirus type 16 in tumor tissue of low-stage squamous carcinoma of the uterine cervix in relation to ploidy grade and prognosis
51. DNA-cytometry in abnormal Pap-smears of the cervix
52. Simultaneous effects of aneuploidy and oncogenic human papillomavirus on histological grade of cervical intraepithelial neoplasia
53. Combined analysis of cervical smears. Cytopathology, image cytometry and in situ hybridization
54. Retrospective DNA analyses in cervical dysplasia as related to neoplastic progression or regression
55. The significance of HPV 16, 18 infection and the DNA ploidy associated with the progression of uterine cervical dysplasia]
56. Flow cytometric analysis of DNA content in cervical lesions
57. Dysplasia and HPV infection initially detected by DNA analysis in cytomorphologically normal cervical smears
58. Correlations between the HPV type, DNA index and evolution of cervical intraepithelial neoplasia (CIN)
59. Semi-automated diagnosis of cervical intra-epithelial neoplasia grade 2 by the measurement of acid labile DNA in cytologically normal nuclei
60. Proliferation and DNA aneuploidy in mild dysplasia imply early steps of cervical carcinogenesis
61. Comparison between flow cytometry and single cell cytophotometry for DNA content analysis of the uterine cervix
62. Flow cytometric DNA analysis as a diagnostic aid for cervical condyloma and cancer
63. The suitability of DNA cytometry for the prediction of the histological diagnosis in women with abnormal cervical smears
64. Discrimination of DNA ploidy patterns by order statistics
65. Comparative quantitative DNA-measurements on Feulgen-stained cervical epithelial cells
66. DNA content of cervical intraepithelial neoplasia studied by two- wavelength Feulgen cytophotometry
67. DNA measurements of cervical epithelial cells in combination with scanning electron microscopy
68. Toward objective quality assurance in cervical cytopathology. Correlation of cytopathologic diagnoses with detection of high-risk human papillomavirus types
69. Cellular and molecular pathogenesis of cancer of the cervix
70. Chromosomal abnormalities in HPV-16-immortalized oral epithelial cells
71. Human papillomavirus. International Academy of Cytology Task Force summary. Diagnostic Cytology Towards the 21st Century: An International Expert Conference and Tutorial
72. Oncogenic human papillomaviruses and ploidy in cervical lesions
73. Relevance of human papillomavirus screening in management of cervical intraepithelial neoplasia
74. Can HPV typing predict the behaviour of cervical epithelial neoplasia?
75. Spontaneous resolution of cervical warty atypia: The relevance of clinical and nuclear DNA features: A prospective study
76. Histologic, nuclear DNA, and human papillomavirus studies of cervical condylomas
77. Cervical papillomavirus infection in diethylstilbestrol-exposed progeny
78. Ploidy and condylomata
79. False positive cervical smears: A cytometric and histological study
80. HPV DNA testing in cervical cancer screening: Results from women in a high-risk province of Costa Rica
81. Human papillomavirus DNA testing for cervical cancer screening in low-resource settings
82. HPV DNA testing of self-collected vaginal samples compared with cytologic screening to detect cervical cancer